Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 120, 219-225
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine, 2012
- Antisense therapy and emerging applications for the management of dyslipidemiaJournal of Clinical Lipidology, 2011
- Zymosan-mediated inflammation impairs in vivo reverse cholesterol transportJournal of Lipid Research, 2011
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophagesEuropean Journal of Immunology, 2003
- Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart StudyAtherosclerosis, 1995
- TREATMENT OF DIABETES WITH GLUCOMANNAN (KONJAC MANNAN)The Lancet, 1979
- Stimulation by insulin of rat liver β-hydroxy-β-methylglutaryl coenzyme A reductase and cholesterol-synthesizing activitiesBiochemical and Biophysical Research Communications, 1973
- Reduction of Blood Cholesterol in ManCirculation, 1953